COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2411: Articles 24101-24110  | Next

Syncytia formation by SARS-CoV-2 infected cells
Buchrieser, J., Dufloo, J., Hubert, M., Monel, B., Planas, D., Rajah, M. M., Planchais, C., Porrot, F., Guivel-Benhassine, F., van der Werf, S., Casartelli, N., Mouquet, H., Bruel, T., Schwartz, O.
10.1101/2020.07.14.202028 — Posted: 2020-07-14
SARS-CoV-2 uses clathrin-mediated endocytosis to gain access into cells
Bayati, A., Kumar, R., Francis, V., McPherson, P. S.
10.1101/2020.07.13.201509 — Posted: 2020-07-14 Discussion: Onsite
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
Clausen, T. M., Sandoval, D. R., Spliid, C. B., Pihl, J., Painter, C. D., Thacker, B. E., Glass, C. A., Narayanan, A., Majowicz, S. A., Zhang, Y., Torres, J. L., Golden, G. J., Porell, R., Garretson, A. F., Laubach, L., Feldman, J., Yin, X., Pu, Y., Hauser, B., Caradonna, T. M., Kellman, B. P., Martino, C., Gordts, P. L. S. M., Leibel, S. L., Chanda, S. K., Schmidt, A. G., Godula, K., Jose, J., Corbett, K. D., Ward, A. B., Carlin, A. F., Esko, J. D.
10.1101/2020.07.14.201616 — Posted: 2020-07-14 Discussion: Onsite | Offsite
O Group is a protective factor for COVID19 in Basque population
Munoz-Culla, M., Roncancio-Clavijo, A., Martinez, B., Gorostidi, M., Pineiro, L. D., Azcune, A., Alberro, A., Monge-Ruiz, J., Castillo-Trivino, T., Prada, A., Otaegui, D.
10.1101/2020.07.13.20152447 — Posted: 2020-07-14
The prevalence of antibodies to SARS-CoV-2 among blood donors in China
Chang, L., Hou, W., Zhao, L., Zhang, Y., Wang, Y., Wu, L., Xu, T., Wang, L., Wang, J., Ma, J., Wang, L., Zhao, J., Xu, J., Dong, J., Yan, Y., Yang, R., Li, Y., Guo, F., Cheng, W., Su, Y., Zeng, J., Han, W., Cheng, T., Zhang, J., Yuan, Q., Ningshao, X., Wang, L.
10.1101/2020.07.13.20153106 — Posted: 2020-07-14
Clinical Ordering Practices of the SARS-CoV-2 Antibody Test at a Large Academic Medical Center
Wiencek, J. R., Head, C. L., Sifri, C. D., Parsons, A. S.
10.1101/2020.07.12.20152165 — Posted: 2020-07-14
Prehospitalization Proton Pump Inhibitor (PPI) use and Clinical Outcomes in COVID-19
Ramachandran, P., Perisetti, A., Gajendran, M., Jean-Louise, F., Dwivedi, A. K., Goyal, H.
10.1101/2020.07.12.20151084 — Posted: 2020-07-14
Efficacy of Chloroquine or Hydroxychloroquine in COVID-19 Patients: A Systematic Review and Meta-Analysis
Kashour, Z. T., Riaz, M., garbati, M., Aldosary, O., Tlayjeh, H., Gerber, D., Murad, M. H., Sohail, M. R., Kashour, T., Tleyjeh, I. M.
10.1101/2020.07.12.20150110 — Posted: 2020-07-14
Low-Dose Whole-Lung Radiation for COVID-19 Pneumonia
Hess, C. B., Buchwald, Z. S., Stokes, W., Nasti, T. H., Switchenko, J. M., Weinberg, B. D., Rouphael, N., Steinberg, J. P., Godette, K. D., Murphy, D. J., Ahmed, R., Curran, W. J., Khan, M. K.
10.1101/2020.07.11.20147793 — Posted: 2020-07-14 Discussion: Onsite
The Efficacy of IL-6 Inhibitor Tocilizumab in Reducing Severe COVID-19 Mortality: A Systematic Review
Kaye, A. G., Siegel, R.
10.1101/2020.07.10.20150938 — Posted: 2020-07-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).